NCT05460052

Brief Summary

Narcolepsy Type 1 (NT1) is a rare chronic neurological disorder resulting from the selective loss of hypocretin neurons. Patients with NT1 suffer from excessive daytime sleepiness, disrupted nighttime sleep, and cataplexy (emotionally triggered episodes of muscle atonia). The disease is associated with numerous comorbidities such as obesity, metabolic disorders, anxiety-depressive disorders, and attentional disorders, all of which have a strong impact on quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 15, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

August 26, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2023

Completed
Last Updated

January 10, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

May 23, 2022

Last Update Submit

January 9, 2024

Conditions

Keywords

NarcolepsyChronic neurological disorderRegular physical activity

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Narcolepsy Severity Scale (NSS) Score after training period.

    The Narcolepsy Severity Scale is a validated scale exploring the different symptoms of NT1

    before and after 6 weeks of physical activity program (training period)

Secondary Outcomes (12)

  • Narcolepsy Severity Scale (NSS) Score

    At 6 months

  • Compliance with the training program.

    weekly during the training period (up to 6 weeks)

  • Hospital and Anxiety Depression Scale score

    At inclusion, at the end of the training program (6 weeks) and at 6 months

  • Frequency of cataplexy

    every week during de training period (6 weeks)

  • Bron/Lyon Attention Stability Test (BLAST) score

    Parameters will be measured at inclusion, at the end of the training program (6 weeks)

  • +7 more secondary outcomes

Study Arms (2)

Immediate treatment (IT)

Patients randomized to the IT group will begin the training sessions 14 days after the inclusion.

Other: Physical activity training programOther: Personalized training plan.

Waiting list (WL)

Patients randomized to the WL group will receive a weekly phone call for 6 weeks. Then, they will benefit the same training program as IT group (56 days after the inclusion).

Other: Physical activity training programOther: Weekly phone call.Other: Personalized training plan.

Interventions

The physical activity training program will consist of 3 sessions per week for 6 weeks : * 1 session will take place in the Sports Medicine Department of the Croix Rousse Hospital * 2 sessions will take place remotely. They will be led by an educator in Adapted Physical Activity in live video-conference.

Immediate treatment (IT)Waiting list (WL)

Patients included in the WL group will receive a weekly phone call for 6 weeks (waiting period), before starting the physical activity training program described above.

Waiting list (WL)

After the training program, patients of both groups will be given a personalized training plan to be followed for 4 months with regular phone call from the Adapted Physical Activity educator.

Immediate treatment (IT)Waiting list (WL)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with type 1 narcolepsy, sedentary, aged 18 to 65 years. The patients will be recruited from the active file of adult NT1 patients followed in the Sleep Center of the University Hospital of Lyon.

You may qualify if:

  • Diagnosis of Narcolepsy type 1 according to International Classification of Sleep Disorders, 3rd edition (ICSD 3-2014) criteria
  • Patients aged 18 to 65 years
  • Patients beneficiaries of social security
  • Signed consent to participate in the study
  • Access to a video conferencing device (smartphone, tablet or computer)

You may not qualify if:

  • \- Patients with a high level of physical activity on the Ricci and Gagnon Questionnaire (score \>35) and/or regular physical activity in clubs
  • Treatments not stabilized for less than 3 months
  • Cognitive disorders incompatible with the understanding and implementation of the program
  • Medical contraindication to exercise training
  • Patient working night shifts
  • Unstable somatic or psychiatric pathology
  • Severe untreated obstructive sleep apnea syndrome (apnea/hypopnea index \>30/h)
  • Pregnancy in progress or breastfeeding
  • Persons deprived of liberty by a judicial or administrative decision,
  • Persons admitted to a health or social institution for purposes other than research
  • Persons of full age who are subject to a legal protection measure or who are unable to express their consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de médecine du sommeil et des maladies respiratoires

Lyon, 69004, France

Location

Related Publications (1)

  • Ricordeau F, Stauffer E, Putois B, Jaffiol A, Cheylus A, Pouilloux G, Gabriel K, Hoarau E, Bastuji H, Franco P, Herbillon V, Capelle T, Joubert F, Pradat P, Spiegel K, Peter-Derex L. Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional study. Sleep. 2026 Jan 13;49(1):zsaf272. doi: 10.1093/sleep/zsaf272.

MeSH Terms

Conditions

Narcolepsy

Condition Hierarchy (Ancestors)

Disorders of Excessive SomnolenceSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Laure PETER-DEREX, MD, PhD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2022

First Posted

July 15, 2022

Study Start

August 26, 2022

Primary Completion

November 24, 2023

Study Completion

November 24, 2023

Last Updated

January 10, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations